The Administrative Core will be responsible for general administrative oversight and budgetary management of the program. Centralization of these activities will promote efficient management of the program's resources, and will significantly facilitate communication between Project and Core investigators. Dr. Baker, the Program Director, serves as director of this Core and she will have primary responsibility for the overall conduct of the Program Project. The Administrative Core will provide centralized secretarial support, which will assist with scheduling of monthly program meetings of Project Leaders, monthly presentations for the Program research teams, regular discussions and interactions with the Internal Advisory Committee, and yearly External Advisory Board visits, preparing quarterly and yearly financial reports and yearly progress reports, and coordinating administration of the sub-contract to Children's Hospital of Philadelphia. Dr. Baker will assist to ensure that the research performed through this Program Project is in compliance with NIH and Institution requirements
This Core is responsible for the management of the overall Program Project. It provides the administrative structure and scientific leadership to maximize collaborative interactions and scientific exchange among Project Leaders, Core Leaders, and Internal and External Advisory Committees, as well as the necessary administrative and grants accounting support for the program project.
| Pajtler, Kristian W; Wen, Ji; Sill, Martin et al. (2018) Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol 136:211-226 |
| Teitz, Tal; Fang, Jie; Goktug, Asli N et al. (2018) CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med 215:1187-1203 |
| Tsang, Derek S; Burghen, Elizabeth; Klimo Jr., Paul et al. (2018) Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma. Int J Radiat Oncol Biol Phys 100:507-515 |
| Shadrick, William R; Slavish, Peter J; Chai, Sergio C et al. (2018) Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors. Bioorg Med Chem 26:25-36 |
| Roussel, Martine F; Stripay, Jennifer L (2018) Epigenetic Drivers in Pediatric Medulloblastoma. Cerebellum 17:28-36 |
| Waszak, Sebastian M; Northcott, Paul A; Buchhalter, Ivo et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785-798 |
| El Nagar, Salsabiel; Zindy, Frederique; Moens, Charlotte et al. (2018) A new genetically engineered mouse model of choroid plexus carcinoma. Biochem Biophys Res Commun 496:568-574 |
| Nimmervoll, Birgit V; Boulos, Nidal; Bianski, Brandon et al. (2018) Establishing a Preclinical Multidisciplinary Board for Brain Tumors. Clin Cancer Res 24:1654-1666 |
| Vo, BaoHan T; Kwon, Jin Ah; Li, Chunliang et al. (2018) Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Sci Rep 8:8733 |
| ElInati, Elias; Russell, Helen R; Ojarikre, Obah A et al. (2017) DNA damage response protein TOPBP1 regulates X chromosome silencing in the mammalian germ line. Proc Natl Acad Sci U S A 114:12536-12541 |
Showing the most recent 10 out of 208 publications
